Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have, or are suspected to have, a tuberculosis (TB) infection.
- People aged 2 years or older.
- People who have a doctor outside of the NIH (such as a family doctor, lung specialist, or TB specialist) who can manage their TB care, oversee their medication-taking if needed, and watch for any medication side effects.
- People who agree to have their biological samples (such as blood or tissue) stored for future research.
- People who are able to give their own consent to participate, or who have a legally authorised representative able to consent on their behalf.
- People with latent (inactive) TB who have had a positive TB skin test (PPD) or a positive blood test (IGRA) that meets official guidelines — the positive test can have occurred at any point in the past.
- People with active TB of any type, at any location in the body, confirmed by lab tests or tissue sample.
- People with active TB that is strongly suspected by a doctor, even without full lab confirmation.
Who may not be able to join:
- People who are currently incarcerated (in prison or jail).
- People who have been ordered by a court to take TB medications.
- People who are unwilling or unable to follow the prescribed treatment plan.
- People who are currently pregnant.
- Children under the age of 2.
- People who become pregnant after joining the trial, as they would need to be withdrawn from the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Steven M Holland, M.D., National Institute of Allergy and Infectious Diseases (NIAID)
Phone: (301) 443-9460
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Increase in the number of TB patients being actively followed at the NIH CC to provide information on TB patients with DS and drug-resistant disease for hypothesis generation and hands-on experience in the management of TB
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.